Sign in
Not yet recruitingNo phase

Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central Line Bloodstream Infection in Intensive Care Unit in Bangladesh

Key facts

Who runs it
Hiroshima University
Where
Bangladesh and Japan2 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
272 people, planned
Started
15 Feb 2026
Planned end
30 May 2026
Type of study
Interventional
Treatments tested
  • Education with EBP
  • This is a pre- and post- quasi-experimental study.
Record updated
11 February 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Nurse
  • who is a registered nurse in Bangladesh
  • who agrees to participate in this study and the EBP training
  • who will stay at the ICU for 6 months. Patient
  • Irrespective of age and sex, participants must be at least 18 years old
  • Legal guardian of a patient consent to participation in the study

Who cannot take part

  • Nurse
  • Who will not directly involve patient care in ICU. Patient
  • No exclusion criteria

Other criteria

  • Trial 1 \& 2-

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Ventilator acquired pneumonia or pressure ulcer

Where is this trial?

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Quality of care is crucial for preventing adverse events such as infection in the intensive care units (ICUs). The most common ICU-acquired infections include pneumonia such as Ventilator Associated Pneumonia (VAP), Pressure Ulcer (PU), Medical Device Related Pressure Ulcer (MDRPU), and Central Line-Associated Bloodstream Infection (CLABSI). VAP, PU, and MDRPU are significant indicators of the quality of care, while CLABSI is a critical marker of healthcare quality in ICUs, as it is largely preventable through strict adherence to infection control protocols.

Read full original descriptionShow less

VAP is a lung infection that occurs in patients receiving mechanical ventilation for more than 48 hours. A PU is defined as localized damage to the skin or underlying tissue caused solely by pressure, while MDRPUs may also result from friction or pressure from medical devices or other objects. CLABSI is a severe infection caused by improperly inserted or maintained central venous catheters, which underscores the need for stringent catheter management protocols.

The group in the trial

  • Experimental: Trial 1: All Nurses in GICU; Trial 2: All patients admitted in the general GICUTreatment being tested

    Nurses: All nurses who work at GICU of DMCH Patients: all patients who will admit at the assigned GICU during the study period of DMCH

    Treatment: Education with EBP and This is a pre- and post- quasi-experimental study.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central Line Bloodstream Infection in Intensive Care Unit: A Quasi-experimental Study in Bangladesh
Criteria questions
Built from NCT07299799, who can take part
Record updated
11 February 2026